ஏற்ற சினை மருத்துவ நீரிழிவு நோய் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KidneyIntelX found effective in patients with early stage disease ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Investigators found the diabetic kidney disease progression test KidneyIntelX, by RenalytixAI plc, successfully risk stratified a large cohort of patients for disease progression, according to a press release.

Maria marabitoInternational society of nephrology world congressMount sinai clinical diabetes instituteHealio nephrologyCanagliflozin cardiovascular assessment studyKidney diseaseImproving global outcomesInternational societyNephrology world congressசர்வதேச சமூகம் ஆஃப் நெப்ராலஜி உலகம் காங்கிரஸ்ஏற்ற சினை மருத்துவ நீரிழிவு நோய் நிறுவனம்கிட்நீ நோய்மேம்படுத்துகிறது உலகளாவிய ஔட்கம்ஸ்சர்வதேச சமூகம்நெப்ராலஜி உலகம் காங்கிரஸ்